Total Valuation
Tanke Biosciences has a market cap or net worth of $327.59K. The enterprise value is $552.94K.
Market Cap$327.59K
Enterprise Value$552.94K
Share Statistics
Tanke Biosciences has 24,537,615 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding24,537,615
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Tanke Biosciences’s return on equity (ROE) is 0.69 and return on invested capital (ROIC) is 99.64%.
Return on Equity (ROE)0.69
Return on Assets (ROA)-3.69
Return on Invested Capital (ROIC)99.64%
Return on Capital Employed (ROCE)0.65
Revenue Per Employee64.85
Profits Per Employee-2.11K
Employee Count130
Asset Turnover0.11
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Tanke Biosciences is ―. Tanke Biosciences’s PEG ratio is -0.02.
PE Ratio―
PS Ratio79.44
PB Ratio-1.68
Price to Fair Value-1.68
Price to FCF-18.11
Price to Operating Cash Flow-89.35
PEG Ratio-0.02
Income Statement
In the last 12 months, Tanke Biosciences had revenue of 8.43K and earned -274.46K in profits. Earnings per share was -0.01.
Revenue8.43K
Gross Profit6.87K
Operating Income-257.87K
Pretax Income-274.46K
Net Income-274.46K
EBITDA-256.30K
Earnings Per Share (EPS)-0.01
Cash Flow
In the last 12 months, operating cash flow was -25.40K and capital expenditures 8.00, giving a free cash flow of -25.39K billion.
Operating Cash Flow-25.40K
Free Cash Flow-25.39K
Free Cash Flow per Share>-0.01
Dividends & Yields
Tanke Biosciences pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta3.24
52-Week Price Change-34.78%
50-Day Moving Average0.02
200-Day Moving Average0.03
Relative Strength Index (RSI)7.41
Average Volume (3m)3.25K
Important Dates
Tanke Biosciences upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Tanke Biosciences as a current ratio of 0.02, with Debt / Equity ratio of -32.03%
Current Ratio0.02
Quick Ratio0.02
Debt to Market Cap0.21
Net Debt to EBITDA-0.52
Interest Coverage Ratio-15.53
Taxes
In the past 12 months, Tanke Biosciences has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Tanke Biosciences EV to EBITDA ratio is -3.14, with an EV/FCF ratio of -21.73.
EV to Sales95.34
EV to EBITDA-3.14
EV to Free Cash Flow-21.73
EV to Operating Cash Flow-21.73
Balance Sheet
Tanke Biosciences has $37.30K in cash and marketable securities with $140.00K in debt, giving a net cash position of -$102.70K billion.
Cash & Marketable Securities$37.30K
Total Debt$140.00K
Net Cash-$102.70K
Net Cash Per Share>-$0.01
Tangible Book Value Per Share-$0.02
Margins
Gross margin is 88.39%, with operating margin of -3058.90%, and net profit margin of -3255.80%.
Gross Margin88.39%
Operating Margin-3058.90%
Pretax Margin-3255.80%
Net Profit Margin-3255.80%
EBITDA Margin-3040.34%
EBIT Margin-3058.90%
Analyst Forecast
The average price target for Tanke Biosciences is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast-16.67%